Probably would have been the intention post-approval regardless,...

  1. 18,369 Posts.
    lightbulb Created with Sketch. 5231
    Probably would have been the intention post-approval regardless, seems fairly common for Aussie bio/pharma companies. We’re not even at that stage yet though, more likely end up selling this to a US player by the end of the year
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.